Longeveron Inc. (NASDAQ:LGVN), a biopharmaceutical company specializing in regenerative medicine with a market capitalization of $23.81 million, announced the immediate resignation of Mr. Neil Hare ...
Jonathan Rigby, President and CEO of Sernova, stated, “We are thrilled to welcome Ross Haghighat as our new Chair of the Board. His deep industry knowledge and visionary leadership make him the ...
A global team of scientists has made a groundbreaking discovery of a new skeletal tissue known as "lipocartilage," offering ...
Researchers have successfully engineered bi-paternal mice, born from two male parents, that survived to adulthood using embryonic stem cell techniques.
A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a mouse with two male parents -- that lived until adulthood. Their results ...
Researchers in China have achieved what many believed couldn't be done: they've created viable, healthy mice using genetic ...
A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...
A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse—a mouse ...
Scientists in China have manipulated embryonic stem cells to create laboratory mice with two male parents that managed to ...
Under the patronage and in the presence Zaki Nusseibeh, Cultural Adviser to the UAE President and Chancellor of the United ...
Good Morning Washington's Brian van de Graaff speaks to Dr. Chenai Nettey, MD at ROSM about a non-surgical solution, PRP therapy.